Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional

Study of Human Placenta-derived Cells (PDA001) to Evaluate the Safety and Effectiveness for Patients With Active Rheumatoid Arthritis

ClinicalTrials.gov ID: NCT01261403

Public ClinicalTrials.gov record NCT01261403. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 12:51 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Double- Blind, Placebo-controlled, Multi-center Study to Evaluate the Safety and Efficacy of Intravenous Infusion of Human Placenta-Derived Cells (PDA001) for the Treatment of Adults With Active Rheumatoid Arthritis

Study identification

NCT ID
NCT01261403
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Celularity Incorporated
Industry
Enrollment
26 participants

Conditions and interventions

Interventions

  • PDA001 Biological
  • Vehicle Controlled Placebo Drug

Biological · Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2010
Primary completion
Jan 31, 2012
Completion
Aug 31, 2013
Last update posted
Jul 21, 2020

2010 – 2013

United States locations

U.S. sites
16
U.S. states
11
U.S. cities
15
Facility City State ZIP Site status
Pinnacle Research Group Anniston Alabama 36207
Advanced Pain Research Institute Arcadia California 91007
UCLA Los Angeles California 90095
Desert Medical Advances Palm Desert California 92260
Sanitas Research Coral Gables Florida 33134
Compass Research, LLC Orlando Florida 32806
Progressive Medical Research Port Orange Florida 32127
Four Rivers Clinical Research Inc. Paducah Kentucky 42003
Arthritis and Diabetes Clinic, Inc Monroe Louisiana 71203
St. Paul Rheumatology, PA Eagan Minnesota 55121
SNS Rheumatology Lakewood New Jersey 08701
David R. Mandel, MD, Inc. Mayfield Ohio 44143
Health Research of Oklahoma Oklahoma City Oklahoma 73103
Health Research Institute Oklahoma City Oklahoma 73109
Altoona Center for Clinical Research Duncansville Pennsylvania 16635
Metroplex Clinical Research Center Dallas Texas 75231

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01261403, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 21, 2020 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01261403 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →